FITC-labeled ODN 1018 (sodium)

Product Description: FITC-labeled ODN 1018 (sodium),an oligodeoxynucleotide, is a TLR-9 agonist. FITC-labeled ODN 1018 (sodium) can be used to evaluate CpG ODN cellular uptake and localization by confocal laser-scanning microscopy (excitation 495 nm, emission 520 nm) or flow cytometry.

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Eng NF, et al. The potential of 1018 ISS adjuvant in hepatitis B vaccines: HEPLISAV™ review. Hum Vaccin Immunother. 2013 Aug;9(8):1661-72./[2]Friedberg JW, et al. Phase II study of a TLR-9 agonist (1018 ISS) with rituximab in patients with relapsed or refractory follicular lymphoma. Br J Haematol. 2009 Aug;146(3):282-91.

Molecular Weight: 8171.00

Compound Purity: 98.71

Research Area: Inflammation/Immunology

Solubility: 10 mM in H2O

Target: Toll-like Receptor (TLR)

• Artikelnummer: MEXHY-150724B-10
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-150724B-10
• Verpackungseinheit: 10 mg
• Mengeneinheit: STK